This protocol is judged by an institutional evaluation board, an impartial group that reviews any scientific trials involving human beings. If a review will involve a Schedule I drug, once the board approves the protocol as ethical, the scientists really have to apply for an investigational new drug (IND) range from your FDA.copyright initially gr